Brooks, Moore & Associates, Inc. Abbott Laboratories Transaction History

Brooks, Moore & Associates, Inc.

$168 Million
Q3 2024

A detailed history of Brooks, Moore & Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Brooks, Moore & Associates, Inc. holds 39,827 shares of ABT stock, worth $4.69 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

39,827

Previous 39,827 -0.0%

Holding current value

$4.69 Million

Previous $4.14 Million 9.71%

% of portfolio

2.69%

Previous 2.67%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$100.73 - $112.44 $104,255 - $116,375	1,035 Added 2.67%	39,827 $4.14 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $67,135 - $74,148	-613 Reduced 1.56%	38,792 $4.41 Million
Q4 2023 Feb 15, 2024	SELL	$90.19 - $110.4 $21,645 - $26,496	-240 Reduced 0.61%	39,405 $4.34 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $19,106 - $22,924	-200 Reduced 0.5%	39,645 $3.84 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $90,702 - $101,061	-900 Reduced 2.21%	39,845 $4.34 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $464,249 - $546,449	-4,793 Reduced 10.53%	40,745 $4.13 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $28,518 - $33,456	300 Added 0.66%	45,538 $5 Million
Q3 2022 Nov 17, 2022	SELL	$96.76 - $112.03 $29,028 - $33,609	-300 Reduced 0.66%	45,238 $4.38 Million
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $17,249 - $20,849	-169 Reduced 0.37%	45,538 $4.95 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $38,766 - $47,273	-340 Reduced 0.74%	45,707 $5.41 Million
Q4 2021 Feb 04, 2022	SELL	$115.53 - $141.46 $43,323 - $53,047	-375 Reduced 0.81%	46,047 $6.48 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $23,332 - $25,812	-200 Reduced 0.43%	46,422 $5.48 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $31,737 - $37,359	300 Added 0.65%	46,622 $5.41 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $7,074 - $8,334	65 Added 0.14%	46,322 $5.55 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $56,700 - $61,786	-540 Reduced 1.15%	46,257 $5.07 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $75,603 - $91,814	-825 Reduced 1.73%	46,797 $5.09 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $507,276 - $649,250	-6,625 Reduced 12.21%	47,622 $4.35 Million
Q1 2020 Apr 22, 2020	SELL	$62.82 - $91.86 $100,386 - $146,792	-1,598 Reduced 2.86%	54,247 $4.28 Million
Q4 2019 Jan 30, 2020	SELL	$78.51 - $87.4 $37,292 - $41,515	-475 Reduced 0.84%	55,845 $4.85 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $106,555 - $115,539	-1,302 Reduced 2.26%	56,320 $4.71 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $455,500 - $531,250	-6,250 Reduced 9.79%	57,622 $4.85 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $611,872 - $739,754	-9,240 Reduced 12.64%	63,872 $5.11 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $4.79 Million - $5.43 Million	73,112 New	73,112 $5.29 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooks, Moore & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brooks, Moore & Associates, Inc. with notifications on news.

Account

Brooks, Moore & Associates, Inc. Abbott Laboratories Transaction History